| Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo ZA Wainberg, A Anghel, AJ Desai, R Ayala, T Luo, B Safran, MS Fejzo, ... Clinical Cancer Research 16 (5), 1509-1519, 2010 | 264 | 2010 |
| Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancer ZA Wainberg, A Anghel, AM Rogers, AJ Desai, O Kalous, D Conklin, ... Molecular cancer therapeutics 12 (4), 509-519, 2013 | 89 | 2013 |
| Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice Y Liu, C Yan, Y Wang, Y Nakagawa, N Nerio, A Anghel, K Lutfy, ... Endocrinology 147 (11), 5061-5068, 2006 | 88 | 2006 |
| Repeated stress alters the ability of nicotine to activate the hypothalamic–pituitary–adrenal axis K Lutfy, MC Brown, N Nerio, O Aimiuwu, B Tran, A Anghel, TC Friedman Journal of neurochemistry 99 (5), 1321-1327, 2006 | 48 | 2006 |
| Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake A Anghel, CAM Jamieson, X Ren, J Young, R Porche, E Ozigbo, ... Neuroscience 167 (2), 554-566, 2010 | 36 | 2010 |
| Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes Y Wang, Y Nakagawa, L Liu, W Wang, X Ren, A Anghel, K Lutfy, ... Diabetologia 54, 440-450, 2011 | 32 | 2011 |
| ADRM 1‐amplified metastasis gene in gastric cancer MS Fejzo, L Anderson, HW Chen, A Anghel, J Zhuo, R Anchoori, R Roden, ... Genes, Chromosomes and Cancer 54 (8), 506-515, 2015 | 28 | 2015 |
| Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term … VP Espinosa, Y Liu, M Ferrini, A Anghel, Y Nie, PV Tripathi, R Porche, ... Neuroscience 156 (3), 788-799, 2008 | 25 | 2008 |
| Expression of p16 in colon cancer and cyclin D1 in gastric cancer predicts response to CDK4/6 inhibition in vitro ZA Wainberg, A Yufa, A Anghel, AM Rogers, T Manivong, S Adhami, ... Cancer Research 74 (19_Supplement), 4557-4557, 2014 | 6 | 2014 |
| Identification of predictive markers of response in colorectal cancer following treatment with dasatinib, an orally active tyrosine kinase inhibitor of ABL and SRC ZA Wainberg, J Dering, C Ginther, A Anghel, O Kalous, A Desai, JR Hecht, ... Journal of Clinical Oncology 26 (15_suppl), 14688-14688, 2008 | 5 | 2008 |
| Morphine treatment selectively regulates expression of rat pituitary POMC and the prohormone convertases PC1/3 and PC2 Y Nie, MG Ferrini, Y Liu, A Anghel, EVP Espinosa, RC Stuart, K Lutfy, ... Peptides 47, 99-109, 2013 | 4 | 2013 |
| Biologic effects of NVP-BEZ235, an orally available dual PI3K/mTOR inhibitor, in human breast, lung, colon, pancreas, and liver cancer cell lines in vitro. R Finn, J Dering, D Portillo, A Desai, S Adhami, D Conklin, O Kalous, ... CANCER RESEARCH 69, 2009 | 2 | 2009 |
| COMBINATION STRATEGIES USING KINASE INHIBITORS IN COLORECTAL CANCER IN VITRO J Lorber, A Anghel, ZA Wainberg JOURNAL OF INVESTIGATIVE MEDICINE 58 (1), 131-131, 2010 | | 2010 |
Ondrej KalousUCLA Translational Oncology Research Lab, Jonsson Comprehensive Cancer Center, Department ofVerified email at mednet.ucla.edu
